Except for Day 1, all combination groups were more effective in reducing MCF-7 breast cancer cell growth compared to CGA or Arc alone, whereas CA + CGA + Arc was more effective than CGA and Arc, even on Day 1 (Figure 3A and Table S4). The gene discussed is ARC; the disease is breast cancer.